Parkinson hastalığının ilk teşhis tahmini için hafif bir beyin omurilik sıvısı biyobelirteç tabanlı model: model geliştirme, dış doğrulama ve yerel dağıtım.

Araştırma özeti

Aşağıdaki metin kaynak makalenin lisansı doğrulanmış orijinal özetidir. cc by

BackgroundDespite substantial progress in biomarker research, Parkinson's disease (PD) still lacks widely validated, easily deployable diagnostic tests for reliable early-stage detection, particularly in resource-limited circumstances.ObjectiveThis study aimed to develop and externally validate a lightweight machine learning model for the first-diagnosis prediction of PD using baseline cerebrospinal fluid (CSF) biomarkers from the Parkinson's Progression Markers Initiative (PPMI).MethodsBaseline CSF data from 665 participants (PD = 415, controls = 190, SWEDD = 60) were used. Five machine learning classifiers-L2-regularized logistic regression (L2-LR), random forest (RF), histogram-based gradient boosting (HistGB), support vector machine with RBF kernel (SVM-RBF), and multilayer perceptron (MLP)-were trained and compared. Feature selection focused on five core CSF biomarkers (Aβ42, α-synuclein, total tau, phosphorylated tau181 and hemoglobin). Model performance was evaluated using AUC, PR-AUC, and Brier scores, followed by isotonic calibration and independent validation using the University of Pennsylvania dataset.ResultsA lightweight, biomarker-based RF model effectively distinguishes first-diagnosis PD cases using limited baseline CSF indicators. Its offline Streamlit deployment offers a practical tool for resource-limited settings, bridging the gap between computational prediction and real-world neurological diagnosis.

İlgili konular